Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 5Phase 3 4Phase 1/2 4Phase 4 3Phase 1 3Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 65INDUSTRY 19OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 4Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parotid Gland Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1Locally Advanced Rectal Cancer 1Liver Neoplasms 1Leukemia, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Diseases 1EGFR Positive Non-small Cell Lung Cancer 1Colorectal Neoplasms 1Burkitt Lymphoma 1Advanced Primary Liver Cancer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER_GOV × Multiple Myeloma × Clear all
NCT07085559 2025-07-25

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Anhui Provincial Hospital

Phase EARLY_PHASE1 Recruiting
36 enrolled
Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡